Northwestern Mutual Wealth Management
LTRN icon

Northwestern Mutual Wealth Management’s Lantern Pharma LTRN Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio LTRN Stock Details LTRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$685 Hold
500
– – ﹤0.01% 3811
2025
Q4 		$1.51K Hold
500
– – ﹤0.01% 3550
2025
Q3 		$2.17K Hold
500
– – ﹤0.01% 3366
2025
Q2 		$1.58K Buy
+500
New +$1.69K ﹤0.01% 3314

Other funds holding LTRN

BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Northwestern Mutual Wealth Management's LTRN Position: Q1 2026 in Review

Northwestern Mutual Wealth Management held its Lantern Pharma (LTRN) position steady in Q1 2026 at 500 shares worth $685. The position accounts for ﹤0.01% of the portfolio, ranked #3811.

Northwestern Mutual Wealth Management first reported a position in LTRN in Q2 2025 and has held it in 4 quarters since. The position peaked at $2.17K in Q3 2025. 33 funds tracked by Wall St. Rank hold LTRN as of Q1 2026.

  • Northwestern Mutual Wealth Management held 500 shares of Lantern Pharma worth $685 as of Q1 2026.
  • Northwestern Mutual Wealth Management left its Lantern Pharma share count unchanged in Q1 2026.
  • Lantern Pharma made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q1 2026, its #3811 holding.
  • Northwestern Mutual Wealth Management first reported a position in Lantern Pharma in Q2 2025 and has held it in 4 quarters since.
  • Northwestern Mutual Wealth Management's Lantern Pharma position peaked at $2.17K in Q3 2025.
  • 33 funds tracked by Wall St. Rank held Lantern Pharma as of Q1 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.